Do Cargo Membrane Fluidity and Microdomain Formation Impact Motor Protein-Based Motility?
货物膜的流动性和微区的形成会影响基于运动蛋白的运动吗?
基本信息
- 批准号:9813133
- 负责人:
- 金额:$ 45.44万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-08-15 至 2023-08-31
- 项目状态:已结题
- 来源:
- 关键词:AgeAntibodiesAuthorshipAutomobile DrivingBinding SitesBiophysicsCellsCellular MembraneCholesterolDataDeteriorationDiseaseEukaryotic CellFirst Generation College StudentsFoundationsFunctional disorderFundingFutureGoalsHealthIn VitroInvestigationKinesinLightLinkLiquid substanceLocationMembraneMembrane FluidityMembrane LipidsMembrane MicrodomainsMicrotubulesMinorityMinority-Serving InstitutionModelingMolecularMotorNatureNerve DegenerationNeurodegenerative DisordersNeuronsPaperPathologyPhysiologicalPositioning AttributeProcessProductionPropertyProteinsPublishing Peer ReviewsRegulationReportingResearchRoleScienceSystemTestingVesicleWorkbasecareercell motilityexperimental studyfluidityin vitro Assayin vivoneurological pathologynew therapeutic targetoptical trapssingle moleculesystems researchtherapeutic targettoolundergraduate student
项目摘要
Project Summary/Abstract
The goal of this renewal application is to elucidate the impact of the lipid membrane enclosing cellular cargos
on the function of the major microtubule-based motor protein kinesin-1. Motor protein-based motility underlies
many physiologically important processes, including the delivery of vesicular cargos from one subcellular
location to another in neurons. Dysfunctions in this intracellular motility are implicated in many diseases,
including neurodegeneration. While the properties of motor proteins have been extensively studied both in vivo
and in vitro, many important questions remain, including how the properties of the cargo itself impact motor
function. The central hypothesis of this proposal is that the fluid nature of the cargo membrane and the
formation of microdomains in the membrane are key regulators of motor protein-based motility. In cells, motor
proteins often work in small teams to move membrane-bound, cargo-containing vesicles. Using traditional in
vitro cargos that lack an enclosing membrane, the motility of the cargo are shown to correlate positively with
the number of motors actively moving that cargo. The importance of the cargo membrane in determining the
number of motors in a team has long been proposed. First, membrane fluidity can enable the redistribution and
clustering of motor proteins near the microtubule. Second, membrane microdomains can serve as preferential
binding sites that cluster motors. Both mechanisms can increase the number of motors that are available to
move the cargo as a team. Crucially, most cargos in current in vitro assays still lack the physiological
membrane. Thus, quantitative investigations of these proposed mechanisms are limited by a lack of
appropriate in vitro experimental systems.
To close this major gap, during the current funding period, the research team combined advances in
membrane biophysics with established single-molecule optical trapping to characterize the motility of
membrane-enclosed cargos in vitro. Using this new in vitro experimental system, the research team uncovered
the first direct link that the presence of a fluid membrane positively impacts the motility of the major
microtubule-based motor protein kinesin. Preliminary analyses further indicate that the increase in cargo
motility correlates with an increase in the number of kinesins moving the cargo. Together, this recent work lays
the foundation for the next funding period, when the research team will directly test the central hypothesis that
cargo-membrane fluidity and microdomain formation are key regulators of motor protein-based motility.
Accomplishing the proposed Aims will establish the in vitro system used in this proposal as a controlled
experimental platform for interrogating the physiological regulation of motor proteins. Findings of the proposed
studies have the potential to shed light on the molecular mechanisms underlying diseases, including
neurodegeneration. Both new investigations and novel therapeutic targets and strategies to mitigate
neurological pathology and to promote cellular health will arise from the studies proposed here.
项目总结/文摘
项目成果
期刊论文数量(5)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Cargo diffusion shortens single-kinesin runs at low viscous drag.
货物扩散缩短了单驱动蛋白在低粘滞阻力下的运行时间。
- DOI:10.1038/s41598-019-40550-5
- 发表时间:2019
- 期刊:
- 影响因子:4.6
- 作者:Wilson,JohnO;Quint,DavidA;Gopinathan,Ajay;Xu,Jing
- 通讯作者:Xu,Jing
Cholesterol in the cargo membrane amplifies tau inhibition of kinesin-1-based transport.
- DOI:10.1073/pnas.2212507120
- 发表时间:2023-01-17
- 期刊:
- 影响因子:11.1
- 作者:
- 通讯作者:
Tuning ensemble-averaged cargo run length via fractional change in mean kinesin number.
- DOI:10.1088/1478-3975/abf5b3
- 发表时间:2021-05-19
- 期刊:
- 影响因子:2
- 作者:Wilson JO;Zaragoza AD;Xu J
- 通讯作者:Xu J
Native kinesin-1 does not bind preferentially to GTP-tubulin-rich microtubules in vitro.
天然驱动蛋白-1 在体外不会优先与富含 GTP 微管蛋白的微管结合。
- DOI:10.1002/cm.21386
- 发表时间:2017
- 期刊:
- 影响因子:0
- 作者:Li,Qiaochu;King,StephenJ;Xu,Jing
- 通讯作者:Xu,Jing
A fluid membrane enhances the velocity of cargo transport by small teams of kinesin-1.
流体膜提高了小组驱动蛋白-1 的货物运输速度。
- DOI:10.1063/1.5006806
- 发表时间:2018
- 期刊:
- 影响因子:0
- 作者:Li,Qiaochu;Tseng,Kuo-Fu;King,StephenJ;Qiu,Weihong;Xu,Jing
- 通讯作者:Xu,Jing
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jing Xu其他文献
Jing Xu的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jing Xu', 18)}}的其他基金
Dissecting Behavioral and Neural Mechanisms of Hand Dexterity after Stroke for Effective Rehabilitation
剖析中风后手部灵活性的行为和神经机制,以实现有效康复
- 批准号:
10803644 - 财政年份:2023
- 资助金额:
$ 45.44万 - 项目类别:
Anti-Mullerian hormone actions to control primate folliculogenesis
抗缪勒氏管激素作用控制灵长类动物卵泡发生
- 批准号:
9274843 - 财政年份:2015
- 资助金额:
$ 45.44万 - 项目类别:
Anti-Mullerian hormone actions to control primate folliculogenesis
抗缪勒氏管激素作用控制灵长类动物卵泡发生
- 批准号:
9126576 - 财政年份:2015
- 资助金额:
$ 45.44万 - 项目类别:
相似海外基金
University of Aberdeen and Vertebrate Antibodies Limited KTP 23_24 R1
阿伯丁大学和脊椎动物抗体有限公司 KTP 23_24 R1
- 批准号:
10073243 - 财政年份:2024
- 资助金额:
$ 45.44万 - 项目类别:
Knowledge Transfer Partnership
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
- 批准号:
10752129 - 财政年份:2024
- 资助金额:
$ 45.44万 - 项目类别:
CAREER: Next-generation protease inhibitor discovery with chemically diversified antibodies
职业:利用化学多样化的抗体发现下一代蛋白酶抑制剂
- 批准号:
2339201 - 财政年份:2024
- 资助金额:
$ 45.44万 - 项目类别:
Continuing Grant
Isolation and characterisation of monoclonal antibodies for the treatment or prevention of antibiotic resistant Acinetobacter baumannii infections
用于治疗或预防抗生素耐药鲍曼不动杆菌感染的单克隆抗体的分离和表征
- 批准号:
MR/Y008693/1 - 财政年份:2024
- 资助金额:
$ 45.44万 - 项目类别:
Research Grant
Discovery of novel nodal antibodies in the central nervous system demyelinating diseases and elucidation of the mechanisms through an optic nerve demyelination model
发现中枢神经系统脱髓鞘疾病中的新型节点抗体并通过视神经脱髓鞘模型阐明其机制
- 批准号:
23K14783 - 财政年份:2023
- 资助金额:
$ 45.44万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms controlling the physicochemical properties and functions of supercharged antibodies and development of their applications
阐明控制超电荷抗体的理化性质和功能的机制及其应用开发
- 批准号:
23KJ0394 - 财政年份:2023
- 资助金额:
$ 45.44万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Developing first-in-class aggregation-specific antibodies for a severe genetic neurological disease
开发针对严重遗传神经系统疾病的一流聚集特异性抗体
- 批准号:
10076445 - 财政年份:2023
- 资助金额:
$ 45.44万 - 项目类别:
Grant for R&D
PLA2G2D Antibodies for Cancer Immunotherapy
用于癌症免疫治疗的 PLA2G2D 抗体
- 批准号:
10699504 - 财政年份:2023
- 资助金额:
$ 45.44万 - 项目类别:
Genetic adjuvants to elicit neutralizing antibodies against HIV
基因佐剂可引发抗艾滋病毒中和抗体
- 批准号:
10491642 - 财政年份:2023
- 资助金额:
$ 45.44万 - 项目类别:
Novel Immunogens to Elicit Broadly Cross-reactive Antibodies That Target the Hemagglutinin Head Trimer Interface
新型免疫原可引发针对血凝素头三聚体界面的广泛交叉反应抗体
- 批准号:
10782567 - 财政年份:2023
- 资助金额:
$ 45.44万 - 项目类别:














{{item.name}}会员




